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Background: Well managed diabetes requires active self-management in order to ensure optimal glycaemic
control and appropriate use of available clinical services and other supports. Peer supporters can assist people with
their daily diabetes self-management activities, provide emotional and social support, assist and encourage clinical
care and be available when needed.
Methods: A national database of Australians diagnosed with type 2 diabetes is being used to invite people in
pre-determined locations to participate in community-based peer support groups. Peer supporters are
self-identified from these communities. All consenting participants receive diabetes self-management education
and education manual prior to randomization by community to a peer support intervention or usual care. This
multi-faceted intervention comprises four interconnected components for delivering support to the participants. (1)
Trained supporters lead 12 monthly group meetings. Participants are assisted to set goals to improve diabetes
self-management, discuss with and encourage each other to strengthen linkages with local clinical services
(including allied health services) as well as provide social and emotional support. (2) Support through regular
supporter-participant or participant-participant contact, between monthly sessions, is also promoted in order to
maintain motivation and encourage self-improvement and confidence in diabetes self-management. (3) Participants
receive a workbook containing diabetes information, resources and community support services, key diabetes
management behaviors and monthly goal setting activity sheets. (4) Finally, a password protected website contains
further resources for the participants. Supporters are mentored and assisted throughout the intervention by other
supporters and the research team through attendance at a weekly teleconference. Data, including a
self-administered lifestyle survey, anthropometric and biomedical measures are collected on all participants at
baseline, 6 and 12 months. The primary outcome is change in cardiovascular disease risk using the UKPDS risk
equation. Secondary outcomes include biomedical, quality of life, psychosocial functioning, and other lifestyle
measures. An economic evaluation will determine whether the program is cost effective.
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Discussion: This manuscript presents the protocol for a cluster randomized controlled trial of group-based peer
support for people with type 2 diabetes in a community setting. Results from this trial will contribute evidence
about the effectiveness of peer support in achieving effective self-management of diabetes.
Trial registration number: Australian New Zealand Clinical Trials Registry (ANZCTR); ACTRN12609000469213
Keywords: Peer support, Diabetes, Self-management, Support groupBackground
In most countries around the world, diabetes is now one
of the leading chronic diseases; around 4.4% of Austra-
lians are already diagnosed with diabetes (types 1 & 2) in
2007–08 and this number is continuing to rise [1,2]. In
2003, diabetes was responsible for 5.5% of the total bur-
den of disease in Australia, with 92% of this burden due
to Type 2 diabetes (T2DM). People with diabetes are at
significantly greater risk of serious complications such as
heart attack, stroke, blindness, renal failure and lower-
limb amputation [3]. Such complications more than
double the cost of care [4].
Due to the chronic nature of diabetes, much of the
disease management and glycaemic control needs to be
self-managed. The person with diabetes is required to
adopt and maintain lifestyle and behaviour changes
related to diet and exercise, glycaemic control, medica-
tion and integration of clinical care; and collectively,
these steps have been shown to reduce risk of diabetes
complications [5]. People with diabetes require add-
itional resources and support to facilitate and achieve
these changes; and although social and emotional sup-
port can occur through family and friends, most people
require additional supports as well [6], e.g., from peers.
Peer support refers to the provision of emotional, ap-
praisal and informational support from people who have
experiential knowledge of a condition [7]. This support
functions to complement, supplement and extend formal
primary care services. It relies on non-hierarchical, re-
ciprocal relationships, which provide a flexible supple-
ment to formal health services for people with a chronic
disease [7]. In addition, peer support can also foster
understanding and trust of health care staff among
groups who otherwise may be alienated from or have
poor access to health care.
As identified in a World Health Organization (WHO)
Report [8] concerning peer support programs, more re-
search is required to identify the key ‘active’ components
of these programs and particular features which may
contribute to better outcomes. A recent systematic re-
view of peer-led chronic disease self-management pro-
grams concluded that such programs may lead to small,
short term improvements in participants’ self-efficacy,
self-rated health, cognitive symptom management, and
frequency of aerobic exercise [9]. There remains a lackof evidence concerning medium and longer-term clinical
and other outcomes and there is no unequivocal evi-
dence concerning the long-term impact on appropriate
use of health services.
Peers for Progress, a global initiative of the American
Academy of Family Physicians Foundation (AAFPF) [10],
was developed from a WHO consultation that was held
to identify and accelerate global best practices in peer
support for health [11]. This global initiative aims to
strengthen evidence of the value of peer support through
the funding of 14 “evaluation” grants around the world.
The Peers for Progress program initially identified three
core functions [12] and subsequently added a fourth
[11,13] and these are:
i. Assistance & consultation in applying a diabetes
management plan in daily life – (e.g. goal setting,
problem solving, role play behaviours and trouble
shooting)
ii. Social and emotional support – (e.g. encouragement,
empathy, support & skills to deal with stress, simply
“being there”)
iii. Linkages to and assistance in gaining access to
clinical care – (e.g. promote importance of clinical
care, encourage development of communication
skills to enhance interaction with clinicians)
iv.Ongoing support – (e.g. flexible, proactive, as needed,
continuing availability)
In spite of diversity of setting and model of peer sup-
port being implemented in each country, each of the
current trials is evaluating the same four key functions
in order to a) provide a template for global standardization
and program coherence and, at the same time, b) encour-
age flexibility for local tailoring for local implementation
[11,14].
As the largest non-governmental organisation respon-
sible for diabetes in Australia, Diabetes Australia has
representative organisations in each state and territory
of the country. Diabetes Australia–Vic (DA–Vic) has
been providing financial and technical assistance to an
existing community network (ComNet) of peer support
groups for people with diabetes for many years and there
are over 60 groups throughout the state of Victoria.
These groups provide information, resources and
Riddell et al. BMC Public Health 2012, 12:843 Page 3 of 11
http://www.biomedcentral.com/1471-2458/12/843support for people with diabetes, their families and
carers. A 2005 evaluation of the ComNet program [15]
identified several ways in which this program might be
further enhanced to improve access to educational
resources, connections with local health services and
group sustainability. Compared with professionally-led
groups, where the focus may be purely education [6],
and the unstructured and less formal untrained DA-Vic
ComNet support groups, the Australasian Peers for Pro-
gress – Diabetes Project (Aust PfP-DP) aims to imple-
ment and evaluate peer led, group based peer support in
which people with T2DM within a specified local com-
munity meet to share their self-management challenges,
explore and develop strategies to overcome these
challenges and sustain health behaviour change using
the experiences and support of the group. This
program emphasizes formalized training of voluntary lay
supporters/group facilitators with ongoing support and a
clear structure, which identifies active components and
processes conducive to improving daily management of
diabetes, positive behaviour change and linkage and ac-
cess to clinical care.
Methods/Design
Study aims
The aim of this study is to implement and evaluate the
extent to which the Aust PfP-DP improves diabetes con-
trol by the provision of:
i. Assistance and consultation in applying diabetes
management plan in daily life;
ii. Social and emotional support;
iii. Linkages to and assistance in gaining access to
clinical care; and
iv. Ongoing availability of support
The primary outcome is cardiovascular disease (CVD)
risk using the UK Prospective Diabetes Study (UKPDS)
risk equation [16]. We hypothesize that participants re-
ceiving the peer support intervention will achieve a sig-
nificantly greater reduction in CVD risk. Secondary
outcomes include biomedical, quality of life (QoL) and
psychosocial functioning, physical activity, medication
adherence, nutrition and BMI. We hypothesize these
secondary measures will be significantly improved at 12
months following baseline measurement in those receiv-
ing peer support intervention, compared with those not
receiving the intervention. Furthermore, we will evaluate
the cost-effectiveness of the program.
Study design and setting
The study is a cluster randomized controlled evaluation
of a group-based peer support program, implemented
and reported in accordance with the requirements of theCONSORT statement [17] and its extension to cluster
randomized trials [18]. The study is being conducted in
Victoria, Australia, a state that is divided into 79 local
government areas (LGAs) within five regional and three
metropolitan health regions. Community (defined as a
post code area) peer support groups consisting of 10 –
12 participants are recruited, undergo baseline assess-
ment, and then all participants are offered the opportunity
to attend a one day diabetes self-management education
(DSME) program to ensure that the intervention group
does not simply use the sessions to obtain diabetes edu-
cation rather than peer support. Finally, the groups are
randomized to either an intervention arm or usual care
arm with group postcode location being the unit of
randomization. Groups assigned to the intervention arm
participate in the peer support program for 12 months,
while those assigned to the control arm continue with
their usual care. Figure 1 is a CONSORT diagram of the
study design.
Ethics approval
The study received ethics approval from the Monash
University Human Research Ethics Committee (MUH-
REC) Project number CF09/1692 – 2009000920. Partici-
pants were given a detailed participant information sheet
after which signed informed consent from all partici-
pants is obtained.
Eligibility criteria
Participants and peer leaders, able to understand Eng-
lish, aged between 25 – 75 years and diagnosed with
T2DM for more than 12 months are eligible. Partici-
pants are excluded if they have a current debilitating
medical or related condition (e.g. severe mental illness
or end-stage cancer).
Self-identified peer supporters are interviewed by the
project staff using a set script to assess their current dia-
betes management regimen, their attitude with respect
to the involvement of a clinical care team in diabetes
management, their compassion and understanding of
difficulties people with diabetes may encounter and their
attitude towards referral and seeking assistance when
required. Previous life experience, especially working
with groups or as community leaders and language abil-
ities is considered favourably.
Sample size calculations
Sample size was determined by a requirement to have
sufficient power to detect a meaningful difference be-
tween intervention and control group means of partici-
pant UKPDS score changes from baseline to 12 months.
During the study, both groups will age by 1 year, which
will increase their UKPDS risk calculation by identical
amounts [16]. We anticipate this increase would be
Targeted recruitment in 24 locations
Minimum 1 Peer Leader per Location Minimum 10 Participants per Location
Baseline Measures
Randomisation of locations,stratified by health region with block size equal to the number of locations per region
INTERVENTION ARM CONTROL ARM
SUPPORTERS PARTICIPANTS LEADERSPARTICIPANTS
Diabetes Self-Management Education
Peer Supporter training
Intervention
12 monthly meetings
Participant resources
Regular assistance & guidance for peer supporters
Control
Usual Care
6 and 12 Month Measurements
Figure 1 Australasian Peers for Progress – Consort Diagram for Diabetes Project Study Design.
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blood pressure, total cholesterol/HDL cholesterol ratio,
HbA1C, or smoking status. Assuming a standard devi-
ation of 5% in baseline to 12 month UKPDS changes in
both groups, 100 individuals per study arm with 12
month follow-up are required to provide 80% power to
detect, with a 2 sided p-value of 0.05 for significance, a
mean reduction of cardiovascular risk in the peer sup-
port arm that is 2% greater than any mean reduction in
the usual care arm. The clustering of individuals by ac-
tual peer group (intervention arm) or future group
(usual care arm) was not adjusted for because the com-
parisons across clusters are within-person changes over
time and previous studies of UKPDS change in similar
clusters found no clustering effects. Hence 12 groups
and 120 participants per arm are required at baseline.
Recruitment
DA–Vic administers the National Diabetes Services
Scheme (NDSS), an initiative of the Australian Govern-
ment, which contains contact details for more than 85%
of all clinically confirmed cases of diabetes (including
type 1, type 2 and gestational) in Victoria. Benefits of
NDSS registration include access to diabetes related pro-
ducts at subsidized prices [19]. DA–Vic facilitatedcontact with people diagnosed with T2DM in Victoria
and registered on the NDSS database. Diabetes preva-
lence data from each of the 79 local government areas
(LGAs) in Victoria [20] identified 10 regional towns, two
from each non-metropolitan Melbourne health region,
and 12 metropolitan post codes in the three metropol-
itan health regions for recruitment. Locations are suit-
able if the population was more than 10,000 and the
density of NDSS registrants was more than 2.5%. Figure 2
shows group location by health region.
Prospective participants, enrolled on the NDSS data-
base for more than 1 year, who indicated willingness to
be contacted for research purposes, are resident within
the selected location, and are aged between 25 – 75
years are invited by mail to contact the project team if
interested in receiving further information about partici-
pating in the study as a peer supporter or as a group
member. General Practitioners (GPs), community health
centres, pharmacies, diabetes clinics, podiatrists, opto-
metrists and any active DA–Vic ComNet groups or
other community based groups within the selected loca-
tions are also targeted with posters and brochures to in-
crease study exposure.
Self-identified peer supporters and participants with
an interest in the project are sent comprehensive
Figure 2 Australasian Peers for Progress Diabetes Project Group locations in Victorian Health regions. Two locations were selected for
randomisation in four of the five rural health regions. The regional centre of Geelong in the rural health region of Barwon South Western and
each of the three metropolitan health regions had sufficient population and area to support the selection and randomisation of four group
locations. An additional group was initiated as a pilot group in the western Metropolitan health region.
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and the randomisation process. Participants are asked to
return a signed informed consent indicating their agree-
ment to participate whilst acknowledging their ability to
withdraw if desired.
Diabetes self-management education
All enrolled participants (including identified peer sup-
porters) are invited to attend one day of diabetes self-
management education (DSME), held in ten locations
around the state of Victoria. Education is delivered by a
credentialed diabetes educator and accredited practising
dietician from DA–Vic. The seven-hour program covers
basic disease information, good self-management prac-
tice including diet and physical activity, disease compli-
cations and medications. A project specific education
manual is given to each attending participant. Partici-
pants who cannot attend a full day program are sent the
education manual and a copy of a DVD, filmed during
one of the program education sessions and supplemen-
ted with visual material to reiterate DSME messages.Allocation
Upon completion of recruitment (participant and peer
supporter), DSME and baseline measurement, groups
are randomized in each health region (comprising 2 or 4
groups) so that each health region contained an equal
number of intervention and usual care groups. Alloca-
tion to intervention or usual care was governed by a ran-
dom number generation process using Stata statistical
software, Release 11.
Usual care
Participants and supporters from locations allocated to
the control arm continue to receive their usual care and
receive a copy of all anthropometric and biomedical
measurements collected at baseline, 6 & 12 months with
a recommendation to share these results with their clin-
ical team.
Intervention condition
Figure 3 summarizes the different components of the
peer support intervention program. This multi faceted
Figure 3 Australasian Peers for Progress Diabetes Project Intervention components and outcomes.
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to deliver support to the participants.
 Monthly local community based meetings, facilitated
by a trained peer supporter.
 Regular contact between supporters and
participants, in person or by phone, to offer support
and assistance.
 A manual and resource book, developed specifically
for this program.
 Access to a password protected website containing
further information, resources and education
vignettes.
Participants are encouraged and reminded by the sup-
porter to attend all of the scheduled monthly group ses-
sions during which the group members discuss and
share challenges of diabetes management and support
each other to set and achieve goals. Apart from meetings
one and twelve, the content of the group meeting is flex-
ible and is determined by the particular concerns and
characteristics of individual groups. Suggested topics for
discussion include risk assessment, goal setting, linkage
to clinical care, diet, exercise, feet care, optical andmental health. The group members, according to their
needs and interests, arrange visits to the group meetings
by local health care professionals.
Providing support to each other through regular
supporter-participant or participant-participant contact,
between monthly sessions is promoted in order to main-
tain motivation and encourage self-improvement and
confidence in diabetes self management. Participants
and supporters are encouraged to meet socially, for
shared activities (walks, exercise classes) and to motivate
and encourage each other beyond the time spent to-
gether at the monthly meetings.
Participants receive a manual/workbook, to use during
and outside the monthly meetings, which provides edu-
cational information including health recommendations
and guidelines for diabetes management, helpful tips
and advice for managing diabetes, information about
available clinical care and tips on how to facilitate access
to and use clinical care effectively. This manual also has
space for recording goals, challenges, clinical measures
and notes from discussion arising during the meetings.
Participants have access to a password protected web-
site which offers additional resources to support group
meeting discussions and activities. It provides links to
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cipants can easily navigate to relevant pages if they are
looking for specific information regarding their diabetes
management. It also contains recorded vignettes of the
education session delivered to all participants prior to
randomisation.
A bi-monthly newsletter “Support Share Learn
Live” containing project news, support group profiles
and photos, healthy recipes, and information to sup-
plement meeting topics is posted to all intervention
participants.
Supporters are asked to maintain and record; using a
monthly contact record sheet, email or phone contact
with group members throughout the month at which
time they may inform participants about upcoming
meetings or group activities as well as provide additional
support. The monthly contact record also requires sup-
porters to provide details of discussions and topics cov-
ered at each meeting.
Peer supporter training & support
Suitable peer supporters from locations randomized to
the intervention arm are trained over two and a half
days by a credentialed diabetes nurse educator experi-
enced in group facilitation training. Peer supporter train-
ing aims to equip supporters with communication and
group facilitation skills to help them support their group
members to tell their stories, set goals, problem solve,
increase awareness and linkages with the available health
system, optimize self-management behaviours, including
glucose monitoring, dietary changes and physical activ-
ity, as well as provide emotional support. The work with
the research team with respect to data collection includ-
ing reports of group meetings and individual contacts is
reviewed and explained during the training. Additionally,
peer supporters are invited to assist with scheduling
meetings and to locate potential venues for group meet-
ings within their communities.
Peer supporters are supported during the intervention
period through weekly teleconferences with the project
and specialist staff including diabetes educators, dieti-
cians and psychologists. Furthermore, peer supporters
receive a weekly informational e- newsletter about
aspects of diabetes care and self-management, additional
information in response to questions from group mem-
bers and information they might share with their group
members as well as reminders about joining the telecon-
ference the following week and minutes from the pre-
ceding teleconference (Figure 3). Peer supporters are
asked to attend at least one teleconference each month.
These calls, which are recorded, emulate a supportive
peer group meeting in that discussion and conversation
with the project staff will provide organisational and
informational support and the supporters provideexperiential, emotional and social support to each other.
During these teleconferences, supporters review their
group meetings, discuss important events, share stories,
ask questions on behalf of their group members and re-
ceive support from their peers.
Data collection and outcome measures
Baseline data collection is completed prior to randomization
and is accomplished by a self-administered survey, an-
thropometric measurements collected by the study team
or obtained from the participant’s clinical care provider as
well as blood and urine analysis, specifically for the study
or from a recent test requested by the clinical care pro-
vider. Table 1 shows the measurement tools used for data
collection, the method of collection and time points (base-
line, six or 12 months) at which data is collected. An-
thropometric measures are collected by project staff
specifically trained in accordance with standard clinical
measurement methods [21]. Briefly, the left arm circum-
ference is measured to determine the appropriate cuff size
for blood pressure (BP) measurement. BP and pulse is
measured and recorded three times using the Omron
HEM-907 IntelliSense professional digital blood pressure
monitor with at least one minute between readings.
Height is measured using a portable stadiometer height
rod to the nearest 0.5 cm whilst the participant is standing
without shoes. Weight is measured to the nearest 0.1kg
using a Salter portable weighing scale, model 913. Waist
circumference is measured halfway between the lowest rib
and the top of the hipbone using the Novel figure finder
tape measure. Duplicate waist circumference measure-
ment is undertaken for approximately 10% of the partici-
pants for quality assurance. Blood pressure machines and
weight scales are calibrated at least weekly. Pathology la-
boratories providing blood and urine analysis are accre-
dited by the National Association of Testing Authorities
(http://www.nata.asn.au/) and all methods for determining
HbA1c% are NGSP approved (http://www.ngsp.org/).
The primary outcome measure is cardiovascular dis-
ease (CVD) risk using the UKPDS risk calculation [16].
People with diabetes are already at higher risk of CVD
than the general population without diabetes. We con-
sider that a 10% reduction in risk will be clinically sig-
nificant, if we assume that the average risk for our
participants is likely to be 20 – 25% in line with that in a
sample with type 2 diabetes from Australian general
practice [41]. Age at diagnosis, sex, ethnic group, smok-
ing status, HbA1c, systolic blood pressure and total
cholesterol/HDL ratio will be used in the UKPDS equa-
tion to determine CVD risk at baseline and 12 months
[16]. Changes in the CVD risk over time as well as
changes in waist circumference, body mass index (BMI),
weight, and lipid profile will be used to assess diabetes
self-management post intervention. Quality of life
Table 1 Measurement domains, survey tools and collection method used at each data collection time point
Variable Component Measurement tools/Questions Base
line
6
mth
12
mth
Type of
administration
Demographic
Measures
Age at diagnosis ✓ ✓
Health Insurance ✓ ✓ Postal survey
Age, Sex, Country of birth, Living Arrangement (Marital
status), Education, Income, Employment status,
✓ ✓
Ethnicity, Health Care Access, ✓ ✓
Clinical
Information
Current Clinical Measures On insulin, since when, #/day, Most recent
HbA1c,
✓ ✓ ✓
Other medical treatments, past medical history ✓ ✓ Postal survey
List of prescribed medications, last dilated eye
exam/retinal photo, foot exam, Past medical history, ✓ ✓ ✓
Health before, at and
since diagnosis
Pre-diagnosis; at diagnosis and post-diagnosis
conditions
✓ ✓ Postal survey
Anthropometric Waist circumference (Novel Figure Finder Tape Measure) ✓ ✓ ✓ Collected by project
team /or from clinical
care provider (CCP)Blood Pressure (Omron HEM-907 IntelliSense ✓ ✓ ✓
professional digital blood pressure monitor)
Weight (Salter portable weighing scale, model 913) ✓ ✓ ✓
Height (Portable Stadiometer Height Rod) ✓
Pathology HbA1c,Total Cholesterol(TC), TC/HDL ratio ✓ ✓ ✓ Pathology for
study/ CCP
Urine microalbumin, Fasting blood glucose, Trig,
HDL, LDL,
✓ ✓
Behavioural Physical Activity Single physical activity question (# minutes/week) ✓ ✓ ✓ Postal survey
Nutrition Cancer Council Food Frequency Questionnaire [22] ✓ ✓ FFQ
Smoking Current/ever smoked/ FFQ /SDSCA ✓ ✓ ✓ Postal survey
Alcohol Alcohol days/ quantity/ FFQ ✓ ✓ ✓ Postal survey
Self-care activities (SDSCA) Selfcare activities scale with Toobert,
Fisher & Glasgow modifications [23,24]
✓ ✓ ✓ Postal survey
Medication Morisky 8-item [25,26] ✓ ✓ ✓ Postal survey
QOL Assessment of quality of life AQoL-8D [27] and EQ-5D™[28,29] ✓ ✓ ✓ Postal survey
Diabetes Distress Diabetes Distress Screening Instrument: DDS4 [30,31] ✓ ✓ ✓ Postal survey
Depression PHQ-9 [32] ✓ ✓ ✓ Postal survey
Mediators and
Moderators
Health literacy [33] ✓ ✓ ✓ Postal survey
Non-directive vs directive support [12] ✓ ✓
Availability & satisfaction with
diabetes-support from family,
friends & health care team
[34] ✓ ✓ ✓ Postal survey
Sources of Support Who are you supported by? ✓ ✓ ✓ Postal survey
Diabetes Knowledge Michigan Diabetes Research and Training Centre
with modification to Australian context [35]
✓ ✓ Postal survey
Self-Efficacy Diabetes Self-Efficacy Scale [36] ✓ ✓ ✓ Postal survey
Use of
diabetes
services
Health-care utilisation GP details, Travel time, waiting time ✓ ✓ Postal survey
Insurance, NDSS membership, DA-Vic membership,
GP/ specialists/ health professionals visits over
past 6 mths, ECG, vaccinations, hospital stays,
etc. based on RACGP guidelines for T2DM
management
Most recent HbA1c (self-report)
Cost of services
Clinical services Health care utilisation GPAQ ver 2.1 [37] ✓ ✓ Postal survey
Clinical care agreements (annual cycle of care, General
Practice Management Plan, Team Care Arrangement) ✓ ✓ ✓ Postal survey
# visits past 6 mths to diabetes clinician ✓ ✓ ✓ Postal survey
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Table 1 Measurement domains, survey tools and collection method used at each data collection time point (Continued)
Cost Effective
Analysis
# visits past 6 mths to other clinicians ✓ ✓ ✓
# visits past 6 mths for emergency/acute care ✓ ✓ ✓
# overnight stays past 6 mths in hospital (related to
your diabetes)
✓ ✓ ✓
Peer Training/
Quality Improve.
Training effectiveness Usefulness of training ✓ ✓ Postal survey
Extent of content covered
Process
Evaluation
17 item assessment with 3 additional questions
regarding most helpful, least helpful and suggestions
to improve
✓ ✓ Postal survey
+ 2 questions asking availability of participant to other
group members [38-40]
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diabetes distress screening [30,31], self-care activities
[23,24], medication adherence [25,26], food, smoking
and alcohol intake [22], current support systems [34],
known co-morbidities associated with diabetes,
utilization of and satisfaction with available health ser-
vices [37], diabetes knowledge using the Michigan Dia-
betes Research and Training Center Brief Diabetes
Knowledge Test with modification to Australian context
[35], health literacy [33] and confidence of diabetes man-
agement [36] are measured at baseline, six and 12
months.Program evaluation
Glasgow’s RE-AIM framework is being used to evaluate
the program [42]. We are evaluating individual, group,
and system level measures to assess the success of the
program in achieving the key functions of peer support
as specified by the global Peers for Progress Program
Center [11] i.e. Assisting daily management, improving
linkage to clinical care, providing social and emotional
support and provide ongoing support. A process evalu-
ation will determine the implementation fidelity of the
trial and will assist in future refinements of the Aust
PfP-DP.
Group-level measurements
In addition to individual-level measurements as outlined
in Table 1, we will also measure group- and facilitator-
level outcomes, including group effectiveness, satisfac-
tion of group members and peer supporters and team
dynamics, using a range of questions assembled in col-
laboration with the global Peers for Progress group [11]
and based on items generated by Fisher in the Diabetes
Initiative [43] and items from resources and supports for
self-management (RSSM) and Patient Assessment of
Chronic Illness Care (PACIC) [38-40]. Participants andsupporters in the intervention arm are asked to
complete an evaluation of the resources, health care pro-
viders who visited the groups and group meetings and
perceptions of support received by supporters or other
group members.System-level evaluation
Feasibility of further dissemination and implementation of
the Aust PfP-DP will be evaluated according to the five
key dimensions of the RE-AIM framework which includes
systematic measurement of internal validity (i.e. the ability
of the intervention to produce a sustained change in pa-
tient health behaviours, including Effectiveness and Main-
tenance) and external validity (i.e. the potential for the
intervention to be generalized to other settings including
Reach, Adoption, and Implementation) [42]. Outcomes
such as increased utilisation of DA-Vic resources, mem-
berships and expansion of groups as a result of the inter-
vention will also be assessed.
Economic evaluation
The economic evaluation of the Aust PfP-DP will evalu-
ate whether the program delivers ‘value-for-money’. This
will be undertaken through a ‘trial-based evaluation’
(costs and outcomes exactly as per the trial), as well as a
‘modelled economic evaluation’, which will extend the
target population, time horizon and decision context.
The cost data will also be combined with the change in
the quality of life score for participants using the AQoL-
8D [27] in both the trial-based and modelled evaluations.
This will be helpful to consider value-for-money against a
reference threshold (e.g. $50,000 per QALY).
The modelled evaluation will use the UKDPS out-
comes model [44] to translate the changes in clinical
outcomes observed over the relatively short time hori-
zon of the study into potential lifetime reductions in car-
diovascular and other diabetes related risks. The cost
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mated by drawing on Australian disease specific health
expenditure data.
Data analysis
Analysis will be performed based on based on an
intention-to-treat i.e. without regard to the compliance
of individuals within their allocated study arm. Analysis
of covariance (i.e. linear regression models for 12-month
measurements with baseline scores and intervention
arm as co-variates) will estimate the changes from base-
line to 12 months that can be attributed to the peer sup-
port intervention. Analyses will be done firstly on all
individuals who complete follow-up and secondly on all
individuals who were randomized using multiple imput-
ation principles to deal with the missing data in indivi-
duals who do not complete follow-up. All analyses will
be carried out with Stata software. Regression analysis
will be used to determine the extent to which a variety
of individual-, group- and system-level characteristics
are associated with effective implementation and
outcomes.
Discussion
This article provides a comprehensive description of the
methods being used to implement and evaluate a com-
plex community-based randomized controlled trial of
group peer support for people with type 2 diabetes in
Victoria, Australia. The successful implementation of
this trial will provide evidence about the key functions
of peer support identified by the global Peers for Pro-
gress program.
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